Back to search

National and Kapodistrian University of Athens

Εφαρμογή του κανονιστικού πλαισίου σχεδιασμού και διακινδύνευσης της ποιότητας στην ανάπτυξη ταχέως διαλυόμενων σφαιριδίων

Abstract

dc:description

The pharmacotechnical form of pellets present multiple therapeutic and technical advantages, which are attributed to their increased surface, their enhanced flowability and their uniform size and shape. The direct pelletization process is characterized as an attractive alternative to other pelletization techniques as it is a single pot, quick and efficient method, performed in one stage. Design of experiments (DoE), constitutes a set of powerful techniques that leads to the characterization and optimization of a process, through the determination of the most important factors and interactions that influence the important quality characteristics (responses) of the finished product. Effervescent dosage forms are the main category that combines the stability of solid dosage forms and the ease of administration and enhanced acceptance from people with swallowing difficulties of liquid dosage forms. Objective. The objective of the current study was the development, characterization and optimization of rapidly soluble pellets’ manufacturing process, with the use of mixture of effervescent ingredients and soluble excipients, in a fluid bed rotary processor. Moreover, the produced pellets will be able to be administered after being filled in hard gelatin capsules, after being dissolved in the appropriate water quantity or directly in the oral cavity. Finally, the incorporation of active ingredients in the technological platform was studied as well as the mapping of the under discussion process according to the relevant guidelines. Production method and pellets’ characterization. The pellets were prepared with the tangential spray technique in a rotor granulator (Glatt GPCG3, Glatt GmbH, Dresden, Germany) equipped with a powder feeder. The evaluation of the pellets was performed using an Image Analysis System (Leica Qwin V. 2.3, Leica Imaging Systems, Cambridge, England). The Geometric Mean Diameter (GMD), the Geometric Standard Deviation (GSD) and the sphericity factor eR were estimated by the analysis of samples comprising 200 pellets. The analysis was performed using Design Expert® V. 9.0.5.1, Stat-ease Inc, Minneapolis. Experimental design - Results. After the evaluation of previous techniques and finalization of the preliminary studies a risk assessment was applied so as to select the formulation and process factors that potentially affect the critical quality characteristics of the product. These factors were being reevaluated after each design so as to verify the process of the study. Initially a number of experimental designs without active substance was performed. The first design applied was a fractional factorial with 5 factors (Secondary filler, binding material quantity, additional spheronization time, secondary filler quantity, binding material spray rate) and 22 trials for the evaluation of potential important factors. This resulted in the stabilization of the spheronization type as well as the type (xylitol) and the quantity (280g) of the secondary filler, while the quantity and the spray rate of the binding material were selected for further optimization. The proportion of the effervescent component (Sodium bicarbonate, citric acid, tartaric acid) was studied afterwards, through a mixture design with 9 trials and significant effect was observed for the three responses (GMD, GSD and eR) and the proportion of the effervescent components was fixed by the use of Desirability Function technique (citric acid: tartaric acid: sodium bicarbonate – 15.3: 31.3: 53.4). The next step was the application of the powder feeder to the process so as to enhance pellet sphericity and process yield. This was evaluated through a full factorial design with 3 factors (material, addition rate, quantity) and 14 trials and resulted in the selection of sodium bicarbonate as the material added and its quantity along with the addition rate were forwarded for further investigation. After the stabilizing some of the factors and selecting those qualified for further study, the optimization took place through a central composite design with the 4 selected factors and 30 trials in total. The mathematical models that describe the effect of the factors on the responses and their interactions derived and the factors were optimzed using the Desirability Function. All the above mentioned trials had a good yield and all pellets disintegrated in less than 30 seconds. Once the optimization of the placebo mixture and the verification of the results was concluded, the addition to the optimum composition a number of active ingredients with the appropriate properties took place. The active ingredients tested were: Dexamethasone sodium phosphate, prednisolone sodium phosphate, montelucast sodium and desloratadine. They were analyzed for the critical quality attributes and the one for further study was selected.The first design after the incorporation of the active ingredient concerned the identification of its optimum proportion compared to the rest of the ingredients. A mixture design with 9 experiments was applied. Based on the models that derived the mixture factors were optimized (Active ingredient: filler mixture: effervescent components mixture – 2.0: 70.0: 28.0). Once the quantities of the components were finalized, the optimization of the significant factors that were identified through the study of the placebo mixture and the determination of the design space took place, with the execution of a central composite design with 3 factors and 17 trials. Significant models derived for the GMD and eR that were in accordance with those of the previous central composite design. With the utilization of these models the mapping of the process was achieved and the operational space was specified, according to the relevant guidelines. The next stage was the evaluation and verification of the adequate quality of the pellets manufactured according to parameters within the design space on the critical quality attributes already described but also on their stability (to all ICH conditions, normal, intermediate and accelerated) as well as their organoleptic properties. Conclusions. With the current study we achieved a successful approach a manufacturing process of completely soluble effervescent pellets with the technique of direct pelletization through the experimental design approach. During the initial stages of the development the significant factors were screened, which were further evaluated, providing important process know how, that constitutes requirement of the current regulatory framework for the pharmaceutical products (ICH Q8, “Product Development”). The developed process can be considered adequate for the production of sensitive to humidity pharmaceutical products and has the possibility to lead to medicines acceptable for administration to paediatric populations.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2017

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Karatzas, Angelos
  • Καρατζάς, Άγγελος

Subjects

dc:subject × 14

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/42543

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Karatzas, Angelos; Καρατζάς, Άγγελος. Εφαρμογή του κανονιστικού πλαισίου σχεδιασμού και διακινδύνευσης της ποιότητας στην ανάπτυξη ταχέως διαλυόμενων σφαιριδίων. National and Kapodistrian University of Athens, 2017. http://hdl.handle.net/10442/hedi/42543